RDRobert David

Robert David

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert David has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • C. Brenner

    Medizinische Klinik und Poliklinik I, Klinikum Großhadern der LMU, D-81377 München, Germany

    1 shared publication
  • E. Mentele

    Adolph-Butenandt-Institut der LMU, D-80336 München, Germany

    1 shared publication
  • F. Schwarz

    Medizinische Klinik und Poliklinik I, Klinikum Großhadern der LMU, D-81377 München, Germany

    1 shared publication
  • Florian Schwarz

    Department of Diagnostic and Interventional Radiology, University Hospital Augsburg, 86156 Augsburg, Germany

    1 shared publication
  • H. Lickert

    GSF - National Research Center for Environment and Health, D-85764 Neuherberg, Germany

    1 shared publication
  • Heiko Lickert

    GSF—National Research Center for Environment and Health, D-85764 Neuherberg, Germany

    1 shared publication

Latest Publications

  • Open Access

    Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cell

    by Robert David, Veronica Barbara Jarsch, Florian Schwarz, Petra Nathan, Moritz Gegg, Heiko Lickert, Wolfgang-Michael Franz

    Our recent work demonstrated that common cardiovascular progenitor cells are characterized and induced by the expression of the transcription factor mesoderm posterior1 (MesP1) in vertebrate embryos and murine embryonic stem cells. As the proliferative potential of stem cell-derived cardiomyocytes is limited, it is crucial to understand how MesP1 expression is mediated in order to achieve reasonable and reliable yields for novel stem cell-based therapeutic options. As potential upstream regulators of MesP1, we therefore analysed Eomes and Brachyury(T), which had been controversially discussed as being crucial for cardiovasculogenic lineage formation. Wild-type and transgenic murine embryonic stem cell lines, mRNA analyses, embryoid body formation, and cell sorting revealed that the MesP1 positive population emerges from the Brachyury(T) positive fraction. In situ hybridizations using wild-type mouse embryos confirmed that Brachyury(T) colocalises with MesP1 in vivo. Likewise, shRNA-based loss of Brachyury(T) causes a dramatic decrease in MesP1 expression accompanied by reduced cardiac markers in differentiating embryonic stem cells, which is reflected in vivo via in situ hybridizations using Brachyury(T) knock-out embryos where MesP1 mRNA is greatly abolished. We finally defined a 3.4 kb proximal MesP1-promoter fragment which is directly bound and activated by Brachyury(T) via a T responsive element as shown via bandshift, chromatin immuneprecipitation, and reporter assays. Our work contributes to the understanding of the earliest cardiovasculogenic events and may become an important prerequisite for cell therapy, tissue engineering, and pharmacological testing in the culture dish using pluripotent stem cell-derived as well as directly reprogrammed cardiovascular cell types.


  • MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling

    by R. David, C. Brenner, J. Stieber, F. Schwarz, S. Brunner, M. Vollmer, E. Mentele, J. Müller-Höcker, S. Kitajima, H. Lickert, et al.

    ES-cell-based cardiovascular repair requires an in-depth understanding of the molecular mechanisms underlying the differentiation of cardiovascular ES cells. A candidate cardiovascular-fate inducer is the bHLH transcription factor MesP11,2. As one of the earliest markers, it is expressed specifically in almost all cardiovascular precursors and is required for cardiac morphogenesis2,3. Here we show that MesP1 is a key factor sufficient to induce the formation of ectopic heart tissue in vertebrates and increase cardiovasculogenesis by ES cells. Electrophysiological analysis showed all subtypes of cardiac ES-cell differentiation4. MesP1 overexpression and knockdown experiments revealed a prominent function of MesP1 in a gene regulatory cascade, causing Dkk-1-mediated blockade of canonical Wnt-signalling. Independent evidence from ChIP and in vitro DNA-binding studies, expression analysis in wild-type and MesP knockout mice, and reporter assays confirm that Dkk-1 is a direct target of MesP1. Further analysis of the regulatory networks involving MesP1 will be required to preprogramme ES cells towards a cardiovascular fate for cell therapy and cardiovascular tissue engineering. This may also provide a tool to elicit cardiac transdifferentiation in native human adult stem cells.